Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-005192
Filing Date
2022-03-31
Accepted
2022-03-31 16:02:22
Documents
82
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alna-20211231.htm   iXBRL 10-K 3527407
2 EX-23.1 alna-ex23_1.htm EX-23.1 10139
3 EX-31.1 alna-ex31_1.htm EX-31.1 14274
4 EX-31.2 alna-ex31_2.htm EX-31.2 14279
5 EX-32.1 alna-ex32_1.htm EX-32.1 13599
6 GRAPHIC img100212875_0.jpg GRAPHIC 9045
7 GRAPHIC img100212875_1.jpg GRAPHIC 9949
  Complete submission text file 0000950170-22-005192.txt   11759444

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alna-20211231_cal.xml EX-101.CAL 53139
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alna-20211231.xsd EX-101.SCH 61938
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alna-20211231_lab.xml EX-101.LAB 540132
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alna-20211231_pre.xml EX-101.PRE 424510
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alna-20211231_def.xml EX-101.DEF 260322
76 EXTRACTED XBRL INSTANCE DOCUMENT alna-20211231_htm.xml XML 2147179
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

EIN.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38268 | Film No.: 22792306
SIC: 2836 Biological Products, (No Diagnostic Substances)